Naphazoline PCD Pharma Franchise Company
Cafoli Lifecare offers 2 Naphazoline eye drop formulations for the ophthalmic segment, manufactured at WHO-GMP certified facilities and offered to franchise partners with district-wise monopoly rights.
What is Naphazoline?
Naphazoline is an imidazoline-derived alpha-adrenergic agonist used as an ocular decongestant. It constricts the superficial conjunctival blood vessels, reducing redness and swelling of the eye. It is intended for short-term symptomatic use. Further information is available on MedlinePlus.
Therapeutic Applications
Naphazoline eye drops are used for the symptomatic relief of redness and irritation caused by allergic conjunctivitis, dust, smoke, pollution and minor eye irritation. They are prescribed by ophthalmologists and general physicians, and are frequently used in combination products.
Why Naphazoline is a High-Potential Molecule for Distributors
Ocular decongestants are a high-turnover, low-ticket category: relief is felt within minutes, which makes patients loyal repeat buyers, and air pollution and dust keep demand elevated across most Indian cities year round. It is an easy volume addition to an ophthalmic or general chemist portfolio.
Why Choose Cafoli Lifecare
Cafoli provides district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, competitive net rates and complete promotional inputs, with 1000+ franchise partners across India.
References
- MedlinePlus: Naphazoline (ophthalmic)
- PubChem: Naphazoline
Our formulations of Naphazoline find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: